human recombinant interleukin-2 ( il-2 ) and interferon ( ifn ) inducers in combination were evaluated for their in vivo antitumor efficacy in relation to s.c.-implanted adenocarcinoma 755 in c57bl/6 mice .
C0086418
human
C0021756
recombinant interleukin-2